It is highly recommended that pharmaceutical and biotech projects are executed in a fast-paced mode as the patent window is usually small and the investment requirements are high. There is thus significant risk with regards less than perfect execution – either in terms of design/engineering, project execution, project management, qualification or in the final hand-over for the production.
Elomatic, with its over two decades'’ experience in this field, has developed a simple yet proven methodology that ensures that risks are minimized, efficiency maximized and that the overall return on investment is improved. Through this methodology, we offer high-quality designs that streamline the validation process. Additionally, it gives the flexibility to incorporate changes during the project easily, quickly, and consistently.